Related Experiment Videos
[Left ventricular remodeling after myocardial infarction].
T Anguenot1, J P Bassand, Y Bernard
1Service de Cardiologie et Urgences Vasculaires, Centre Hospitalier Régional Saint-Jacques, Besançon.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|May 1, 1992
Summary
Left ventricular remodeling, a process following myocardial infarction, involves changes in heart geometry. Angiotensin converting enzyme inhibitors show promise in limiting this remodeling and improving survival in animal models.
Area of Science:
- Cardiology
- Pathophysiology
Context:
- Left ventricular remodeling (LVR) encompasses structural changes post-myocardial infarction (MI).
- LVR involves infarct expansion and healthy segment dilatation, severity linked to infarct size.
- Ventricular geometry changes, particularly dilatation, impact long-term cardiac failure risk after MI.
Purpose:
- To explore therapeutic interventions targeting post-infarction left ventricular remodeling.
- To investigate the potential of pharmacological agents, specifically angiotensin converting enzyme inhibitors, in limiting LVR.
Summary:
- LVR is a key process after MI, influencing cardiac dysfunction and failure.
- Angiotensin converting enzyme inhibitors have demonstrated efficacy in limiting LVR and improving survival in animal studies.
- While beneficial for LVR, direct extrapolation of these findings to clinical mortality in humans requires further investigation.
Impact:
- Provides insights into managing secondary complications of MI.
- Highlights the potential of pharmacological interventions beyond infarct size reduction.
- Suggests avenues for future clinical trials to confirm therapeutic benefits in human mortality.